Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Rausch

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Plos One|March 25, 2015
Shared investment projects and forecasting errors: setting framework conditions for coordination and sequencing data quality activitiesStephan Leitner, Alexander Brauneis, Alexandra Rausch
Plos One|August 28, 2023
The effects of group adaptation on task performance: An agent-based approachDarío Blanco-Fernández, Stephan Leitner, Alexandra Rausch
Frontiers in Immunology|June 10, 2025
Enhancing tofacitinib's therapeutic efficacy in murine arthritis with a synbiotic formulation comprising <i>Bacillus megaterium</i> DSM 32963 and an Omega-3 fatty acid lysine saltAnnette Zehrer, Alexandra Rausch, Paul M Jordan, et al.
European Journal of Immunology|April 19, 2006
Interleukin-15 mediates protection against experimental tuberculosis: a role for NKG2D-dependent effector mechanisms of CD8+ T cellsAlexandra Rausch, Manuela Hessmann, Alexandra Hölscher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 30, 2009
Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunityTanja Schreiber, Stefan Ehlers, Lisa Heitmann, et al.
Immunobiology|December 3, 2010
DAP10 contributes to CD8(+) T cell-mediated cytotoxic effector mechanisms during Mycobacterium tuberculosis infectionManuela Hessmann, Alexandra Rausch, Dominik Rückerl, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2010
Dendritic polyglycerol sulfates as multivalent inhibitors of inflammationJens Dernedde, Alexandra Rausch, Marie Weinhart, et al.
Experimental Dermatology|December 17, 2010
Inhibition of the IL-2-inducible tyrosine kinase (Itk) activity: a new concept for the therapy of inflammatory skin diseasesArne von Bonin, Alexandra Rausch, Anne Mengel, et al.
Journal of Medicinal Chemistry|January 16, 2024
Discovery of IRAK4 Inhibitors <b>BAY1834845</b> (Zabedosertib) and <b>BAY1830839</b>Ulrich Bothe, Judith Günther, Reinhard Nubbemeyer, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Plos One|March 25, 2015
Shared investment projects and forecasting errors: setting framework conditions for coordination and sequencing data quality activitiesStephan Leitner, Alexander Brauneis, Alexandra Rausch
Plos One|August 28, 2023
The effects of group adaptation on task performance: An agent-based approachDarío Blanco-Fernández, Stephan Leitner, Alexandra Rausch
Frontiers in Immunology|June 10, 2025
Enhancing tofacitinib's therapeutic efficacy in murine arthritis with a synbiotic formulation comprising <i>Bacillus megaterium</i> DSM 32963 and an Omega-3 fatty acid lysine saltAnnette Zehrer, Alexandra Rausch, Paul M Jordan, et al.
European Journal of Immunology|April 19, 2006
Interleukin-15 mediates protection against experimental tuberculosis: a role for NKG2D-dependent effector mechanisms of CD8+ T cellsAlexandra Rausch, Manuela Hessmann, Alexandra Hölscher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 30, 2009
Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunityTanja Schreiber, Stefan Ehlers, Lisa Heitmann, et al.
Immunobiology|December 3, 2010
DAP10 contributes to CD8(+) T cell-mediated cytotoxic effector mechanisms during Mycobacterium tuberculosis infectionManuela Hessmann, Alexandra Rausch, Dominik Rückerl, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2010
Dendritic polyglycerol sulfates as multivalent inhibitors of inflammationJens Dernedde, Alexandra Rausch, Marie Weinhart, et al.
Experimental Dermatology|December 17, 2010
Inhibition of the IL-2-inducible tyrosine kinase (Itk) activity: a new concept for the therapy of inflammatory skin diseasesArne von Bonin, Alexandra Rausch, Anne Mengel, et al.
Journal of Medicinal Chemistry|January 16, 2024
Discovery of IRAK4 Inhibitors <b>BAY1834845</b> (Zabedosertib) and <b>BAY1830839</b>Ulrich Bothe, Judith Günther, Reinhard Nubbemeyer, et al.
Pageof 1